We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.14 | -0.13% | 106.15 | 106.76 | 105.15 | 106.71 | 3,735,828 | 01:00:00 |
From May 2019 to May 2024
Abbott Laboratories' second-quarter revenue from diagnostics climbed to $1.99 billion, with U.S. diagnostics sales rising 23% to $857 million in the quarter. "Abbott Beats Forecasts on Strong Covid-19 Testing Business," published at 7:49 a.m., misstated total diagnostics revenue rose 23% to $857 million.
(END) Dow Jones Newswires
July 16, 2020 08:37 ET (12:37 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
